918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

Bibliographic Details
Main Authors:	Marco Donia, Mads H Andersen, Martin Lauss, Göran Jönsson, Arianna Draghi, Katja Harbst, Inge Svane, Torben Lorentzen, Shawez Khan, Mario Presti, Christopher A Chamberlain, Agnete WP Jensen, Michael D Crowther, Anne-Christine K Rasmussen, Benedetta Albieri
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

762 A combination of functional biomarkers improves identification of the tumor-specific reactive T cell repertoire
by: Marco Donia, et al.
Published: (2020-11-01)

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
by: Arianna Draghi, et al.
Published: (2021-10-01)

1030 Peripheral immunological dynamics of response in pancreatic cancer treated with immune checkpoint inhibitors
by: Marco Donia, et al.
Published: (2023-11-01)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
by: Martin Lauss, et al.
Published: (2020-04-01)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
by: Martin Lauss, et al.
Published: (2017-11-01)

9.18 Developmental Neurobiology, Spring 2003
by: Nedivi, Elly
Published: (2003)

Molecular patterns of resistance to immune checkpoint blockade in melanoma
by: Martin Lauss, et al.
Published: (2024-04-01)

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
by: Marco Donia, et al.
Published: (2021-07-01)

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab
by: Mads Hald Andersen, et al.
Published: (2023-05-01)

363 Identification of dark antigen® reactive T cell receptors from tumor-infiltrating lymphocytes
by: Özcan Met, et al.
Published: (2023-11-01)

Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
by: Marco Donia, et al.
Published: (2023-08-01)

History of the medical licensing examination () in Korea’s Goryeo Dynasty (918-1392)
by: Kyung-Lock Lee
Published: (2015-05-01)

822 IL6R-blockade abolishes the anti-tumor effect of TGFβ-derived immune modulatory vaccination in a murine model of pancreatic cancer
by: Marco Donia, et al.
Published: (2023-11-01)

Immunoprofiles of colorectal cancer from Lynch syndrome
by: Joanna Walkowska, et al.
Published: (2019-01-01)

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
by: Cox, T, et al.
Published: (2000)

Francine Hérail, Un fonctionnaire lettré, Miyoshi no Kiyoyuki (847-918) en son temps
by: Michel Vieillard-Baron
Published: (2017-12-01)

En torno a la conquista cristiana de la Rioja Alta (918-925)
by: David Peterson
Published: (2007-06-01)

A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.
by: El-Andaloussi, S, et al.
Published: (2007)

P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS
by: J. Khwaja, et al.
Published: (2022-06-01)

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.
by: Elstein, D, et al.
Published: (2004)

Fusarisolins A–E, Polyketides from the Marine-Derived Fungus <i>Fusarium solani</i> H918
by: Siwen Niu, et al.
Published: (2019-02-01)

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma
by: Marco Donia, et al.
Published: (2024-05-01)

Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application
by: Niels Junker, et al.
Published: (2011-01-01)

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
by: Christopher Aled Chamberlain, et al.
Published: (2022-03-01)

T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
by: Michael D. Crowther, et al.
Published: (2020-06-01)

An analysis of HLA-A, -B, and -DRB1 allele and haplotype frequencies of 21,918 residents living in Liaoning, China.
by: Xiao-Feng Li, et al.
Published: (2014-01-01)

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
by: Marco Donia, et al.
Published: (2020-10-01)

Comentário ao Recurso Especial nº 1.918.421–SP: desafios da reprodução humana assistida post mortem
by: Rose Melo Vencelau Meireles
Published: (2021-12-01)

Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
by: Nikolaj Pagh Kristensen, et al.
Published: (2022-01-01)

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
by: Shamaila Munir, et al.
Published: (2012-01-01)

Precious Items Piling up Like Mountains: Buddhist Art Production via Fundraising Campaigns in Late Koryŏ Korea (918–1392)
by: Maya Stiller
Published: (2021-10-01)

Development of a Pacific oyster (<it>Crassostrea gigas</it>) 31,918-feature microarray: identification of reference genes and tissue-enriched expression patterns
by: Huvet Arnaud, et al.
Published: (2011-09-01)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
by: Ellebaek Eva, et al.
Published: (2012-08-01)

Durable Clinical Responses and Long-Term Follow-Up of Stage III–IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study—A Brief Research Report
by: Julie Westerlin Kjeldsen, et al.
Published: (2018-09-01)

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot
by: Mads Hald Andersen, et al.
Published: (2012-04-01)

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations
by: Ulla Kring Hansen, et al.
Published: (2020-03-01)

P918: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MRI FOR STAGING PATIENTS IN HIGH RISK SMOLDERING MYELOMA: A PROSPECTIVE TRIAL
by: Claudio Cerchione, et al.
Published: (2023-08-01)

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
by: Uffe Klausen, et al.
Published: (2018-10-01)

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
by: Cathrine Lund Lorentzen, et al.
Published: (2022-10-01)

ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
by: Thomas Morgan Hulen, et al.
Published: (2021-07-01)